Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Dendritic Cell Sarcoma, Interdigitating × polatuzumab vedotin × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 13 Lymphoma, Non-Hodgkin 5 Lymphoma, B-Cell 3 Lymphoma 3 Recurrence 1 Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Hodgkin Disease 1 Burkitt Lymphoma 1

Interventions

Rituximab 2 Cyclophosphamide 2 zanubrutinib 1 venetoclax 1 relmacabtagene autoleucel 1 pirtobrutinib 1 pembrolizumab 1 pegfilgrastim 1 obinutuzumab 1 glofitamab 1 fludarabine 1 axicabtagene ciloleucel 1 Whole-Body Irradiation 1 Vincristine 1 Triamcinolone 1 Tacrolimus 1 Prednisolone 1 Mycophenolic Acid 1 Melphalan 1 Lenalidomide 1 Granulocyte Colony-Stimulating Factor 1 Doxorubicin 1 Dexrazoxane 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡